Aytu Bioscience Stock News

XpresSpa pursues COVID-19 screening, testing at U.S. airports XSPA DGX AYTU HSIC

Top Ranked Momentum Stocks to Buy for April 3rd

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 3rd

Aytu BioScience (NASDAQ:AYTU) has begun shipping its rapid antibody blood test for COVID-19. Shares up 8% premarket.Stryker (NYSE:SYK) has developed a low-cost limited-release emergency response bed

Top Ranked Momentum Stocks to Buy for April 2nd

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 2nd

Luckin Coffee (NASDAQ:LK) -84% on fraud finding.Golar LNG Partners (NASDAQ:GMLP) -55% on dividend cut.Safe-T Group (NASDAQ:SFET) -28% after pricing direct offering.Dynatronics (NASDAQ:DYNT) -22%�

InflaRx N.V. (NASDAQ:IFRX) +54% with doses of first COVID-19 with IFX-1.Qumu (NASDAQ:QUMU) +39%.Chembio Diagnostics (NASDAQ:CEMI) +26% on launching rapid COVID-19 blood test.Safe-T Group (NASDAQ:SFE

Aytu BioScience is a one-trick play around COVID-19 test distribution. The company does not likely have additional value in its product pipeline and is likely t

Doing all it can to get quick COVID-19 tests into the field in the U.S., the FDA has signed off on Emergency Use Authorization for Bodysphere's qualitative (yes or no answer) blood test that detects t

Amarin (NASDAQ:AMRN) -68% after court decision on Vascepa.Delphi Technologies (NYSE:DLPH) -27% on cost reductions.SuperCom (NASDAQ:SPCB) -22%.ElectroCore (NASDAQ:ECOR) -20%.Carnival (NYSE:CCL) -14

“No test is perfect,” counters Little Saigon doctor who has administered 200 tests and ordered 12,000 more.

Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.

The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics

The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics